E-LIB Suche - Ergebnisse für: Shteinberg, M.

1

Diagnostic delay and access to care in bronchiectasis: data..:

Spinou, A. ; Almagro, M. ; Harris, B....
European Respiratory Journal. , 2024

Link: https://doi.org/10.1183/..

2

EPS9.01 Utilizing intestinal organoids to assess in-vitro r..:

Sznadjer, N. ; Leebhoff, S. ; Duran, D....
Journal of Cystic Fibrosis. 23 (2024) - p. S60 , 2024

Link: https://doi.org/10.1016/..

3

P082 Optimizing CFTR modulator therapy management for cysti..:

Livnat, G. ; Cohen-Cymberknoh, M. ; Shoseyov, D....
Journal of Cystic Fibrosis. 23 (2024) - p. S92 , 2024

Link: https://doi.org/10.1016/..

4

P074 Treatment effects of CFTR modulators on people with cy..:

Yaacoby-Bianu, K. ; Heching, M. ; Shmueli, E....
Journal of Cystic Fibrosis. 22 (2023) - p. S86 , 2023

Link: https://doi.org/10.1016/..

5

P293 An intensive protocol for bowel preparation in people ..:

Alterovitch, H. ; Lavi, T. ; Yaacoby-Bianu, K....
Journal of Cystic Fibrosis. 22 (2023) - p. S154 , 2023

Link: https://doi.org/10.1016/..

6

WS02.02 Ovarian reserve in women with cystic fibrosis: is t..:

Cohen-Cymberknoh, M. ; Garber, K. Marks ; Reiter, J....
Journal of Cystic Fibrosis. 22 (2023) - p. S4 , 2023

Link: https://doi.org/10.1016/..

7

P052 Efficacy of elexacaftor/tezacaftor/ivacaftor in people..:

Yaacoby-Bianu, K. ; Dagan, A. ; Cohen-Cymberknoh, M....
Journal of Cystic Fibrosis. 22 (2023) - p. S79 , 2023

Link: https://doi.org/10.1016/..

8

P077 Clinical and functional efficacy of elexacaftor/tezaca..:

Cohen-Cymberknoh, M. ; Sadras, I. ; Kerem, E....
Journal of Cystic Fibrosis. 22 (2023) - p. S87 , 2023

Link: https://doi.org/10.1016/..

9

WS01.02 Trends and outcomes of long-term inhaled antimicrob..:

Shteinberg, M. ; Orenti, A. ; Mei-Zahav, M...
Journal of Cystic Fibrosis. 21 (2022) - p. S1-S2 , 2022

Link: https://doi.org/10.1016/..

10

P044 Treatment benefits of elexacaftor/tezacaftor/ivacaftor..:

Livnat, G. ; Dagan, A. ; Heching, M....
Journal of Cystic Fibrosis. 21 (2022) - p. S73 , 2022

Link: https://doi.org/10.1016/..

11

133 Clinical response to elexacaftor/tezacaftor/ivacaftor i..:

Sadras, I. ; Kerem, E. ; Livnat, G....
Journal of Cystic Fibrosis. 21 (2022) - p. S78-S79 , 2022

Link: https://doi.org/10.1016/..

12

P214 Real-life evaluation of the multi-organ effects of lum..:

Yaacoby-Bianu, K. ; Schnapp, Z. ; Koren, I....
Journal of Cystic Fibrosis. 19 (2020) - p. S117 , 2020

Link: https://doi.org/10.1016/..

13

P266 The effect of lumacaftor/ivacaftor on the severity of ..:

Yaacoby-Bianu, K. ; Shorbaji, N. ; Schnapp, Z...
Journal of Cystic Fibrosis. 18 (2019) - p. S132 , 2019

Link: https://doi.org/10.1016/..

14

P217 Cystic fibrosis with pancreatic insufficiency is assoc..:

Shteinberg, M. ; Ben Lulu, A. ; Downey, D....
Journal of Cystic Fibrosis. 17 (2018) - p. S121 , 2018

Link: https://doi.org/10.1016/..

15

The Q359K/T360K mutation causes cystic fibrosis in Georgian..:

Mei-Zahav, M. ; Stafler, P. ; Senderowitz, H....
Journal of Cystic Fibrosis. 17 (2018) 5 - p. e41-e45 , 2018

Link: https://doi.org/10.1016/..